The N-Glycosylation of Total Plasma Proteins and IgG in Atrial Fibrillation
Biomolecules · 2023
DOI: 10.3390/biom13040605 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, 2023. Verfasst von Branimir Plavša und 11 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmacy and Biochemistry, University of Zagreb, 10000 Zagreb, Croatia. Hauptthemen laut MEDLINE: Atrial Fibrillation. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Croatian Science Foundation.
Abstract (Originalsprache)
Atrial fibrillation is a disease with a complex pathophysiology, whose occurrence and persistence are caused not only by aberrant electrical signaling in the heart, but by the development of a susceptible heart substrate. These changes, such as the accumulation of adipose tissue and interstitial fibrosis, are characterized by the presence of inflammation. N-glycans have shown great promise as biomarkers in different diseases, specifically those involving inflammatory changes. To assess the changes in the N-glycosylation of the plasma proteins and IgG in atrial fibrillation, we analyzed the N-glycosylation of 172 patients with atrial fibrillation, before and six months after a pulmonary vein isolation procedure, with 54 cardiovascularly healthy controls. An analysis was performed using ultra-high-performance liquid chromatography. We found one oligomannose N-glycan structure from the plasma N-glycome and six IgG N-glycans, mainly revolving around the presence of bisecting N-acetylglucosamine, that were significantly different between the case and control groups. In addition, four plasma N-glycans, mostly oligomannose structures and a derived trait that was related to them, were found to be different in the patients who experienced an atrial fibrillation recurrence during the six-month follow-up. IgG N-glycosylation was extensively associated with the CHA2DS2-VASc score, confirming its previously reported associations with the conditions that make up the score. This is the first study looking at the N-glycosylation patterns in atrial fibrillation and warrants further investigation into the prospect of glycans as biomarkers for atrial fibrillation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Pharmacy and Biochemistry, University of Zagreb, 10000 Zagreb, Croatia.
- Magdalena Clinic for Cardiovascular Disease, Krapinske Toplice, Faculty of Medicine, J.J. Strossmayer University in Osijek, 31000 Osijek, Croatia.
- Faculty of Dental Medicine and Health, J.J. Strossmayer University in Osijek, 31000 Osijek, Croatia.
- Department of Cardiology, University Hospital Dubrava, 10000 Zagreb, Croatia.
- Department of Biotechnology, University of Rijeka, 51000 Rijeka, Croatia.
- Faculty of Medicine, J.J. Strossmayer University of Osijek, 31000 Osijek, Croatia.
ORCID-Profile: Branimir Plavša, Janko Szavits-Nossan, Gordan Lauc, Ivan Gudelj
Förderung
- Croatian Science Foundation
Zitieren
APA
Plavša, B., Szavits-Nossan, J., Blivajs, A., Rapčan, B., Radovani, B., Šesto, I., Štambuk, K., Mustapić, V., Đerek, L., Rudan, D., Lauc, G., & Gudelj, I. (2023). The N-Glycosylation of Total Plasma Proteins and IgG in Atrial Fibrillation. Biomolecules. https://doi.org/10.3390/biom13040605
Vancouver
Plavša B, Szavits-Nossan J, Blivajs A, Rapčan B, Radovani B, Šesto I, et al. The N-Glycosylation of Total Plasma Proteins and IgG in Atrial Fibrillation. Biomolecules. 2023. doi:10.3390/biom13040605
BibTeX
@article{Plava2023,
author = {Plavša, Branimir and Szavits-Nossan, Janko and Blivajs, Aleksandar and Rapčan, Borna and Radovani, Barbara and Šesto, Igor and Štambuk, Krešimir and Mustapić, Vito and Đerek, Lovorka and Rudan, Diana and Lauc, Gordan and Gudelj, Ivan},
title = {The N-Glycosylation of Total Plasma Proteins and IgG in Atrial Fibrillation},
journal = {Biomolecules},
year = {2023},
doi = {10.3390/biom13040605}
}
EUVIMED